Related Experiment Videos
[Cardiac valve replacement and simultaneous myocardial revascularization].
Zeitschrift Fur Kardiologie
|January 1, 1983
Summary
Simultaneous cardiac valve replacement and myocardial revascularization is a safe procedure. This combined surgery offers excellent symptomatic improvement for patients with rheumatic valve disease and coronary artery disease.
Area of Science:
- Cardiovascular Surgery
- Cardiac Valve Repair
- Myocardial Revascularization
Context:
- Between 1974 and 1981, 84 patients underwent combined cardiac valve replacement and myocardial revascularization.
- 77 patients had rheumatic valve disease with coexisting coronary artery disease (group I).
- 7 patients had severe coronary artery disease necessitating valve replacement due to papillary muscle necrosis or hemodynamic reasons (group II).
Purpose:
- To evaluate the safety and efficacy of simultaneous cardiac valve replacement and myocardial revascularization.
- To assess the early and late outcomes of this combined surgical approach.
Summary:
- The study included 84 patients, with 77 in group I (rheumatic valve disease + coronary artery disease) and 7 in group II (severe coronary artery disease).
- Mean coronary artery bypass grafts were 1.7 in group I and 2.4 in group II.
- Early mortality was 9.4% (8 patients), with 3 late deaths over a mean follow-up of 20 months.
- 97% of examined survivors showed improvement of at least one functional class.
Impact:
- Simultaneous myocardial revascularization does not substantially increase the risk associated with cardiac valve replacement.
- The combined procedure yields favorable long-term symptomatic improvement and functional outcomes.